FDA Inspection 1126066 — Karl J. Crossen MD
The FDA completed an inspection of Karl J. Crossen MD on July 16, 2020 in Tupelo, MS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 16, 2020
- Fiscal Year
- 2020
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Tupelo, MS (United States)
Additional Details
Clinical Investigator (CI)